Literature DB >> 11958829

5-HT(1A) receptor antagonist p-MPPI attenuates acute ethanol effects in mice and rats.

Nina K Popova1, Elena A Ivanova.   

Abstract

The effect of a selective 5-HT(1A) antagonist, 4-(2'-methoxy-)phenyl-1-[2'-(N-2"-pyridinyl)-p-iodobenzamino-]ethyl-piperazine (p-MPPI), on acute ethanol-induced hypothermia, sleep and suppression of acoustic startle reflex in C3H/He mice and Wistar rats was studied. Administration of p-MPPI at the doses of 0.4, 0.7 and 1.0 mg/kg reduced in a dose-dependent manner the ethanol-induced hypothermia and the sleep time and attenuated the ethanol-induced decrease of acoustic startle reflex magnitude in mice. Similar p-MPPI (0.4 mg/kg) effects on ethanol-induced sleep and hypothermia were obtained in rats. It was concluded that 5-HT(1A) receptors were involved in the mechanisms of the ethanol-induced hypothermia and sleep, and that 5-HT(1A) antagonist increased acute ethanol tolerance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958829     DOI: 10.1016/s0304-3940(01)02519-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  G-protein-gated potassium (GIRK) channels containing the GIRK2 subunit are control hubs for pharmacologically induced hypothermic responses.

Authors:  Alberto C S Costa; Melissa R Stasko; Markus Stoffel; Jonah J Scott-McKean
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

Review 2.  Combined and sequential effects of alcohol and methamphetamine in animal models.

Authors:  Alexandra M Stafford; Bryan K Yamamoto; Tamara J Phillips
Journal:  Neurosci Biobehav Rev       Date:  2021-09-17       Impact factor: 8.989

3.  Risk neurogenes for long-term spaceflight: dopamine and serotonin brain system.

Authors:  N K Popova; A V Kulikov; E M Kondaurova; A S Tsybko; E A Kulikova; I B Krasnov; B S Shenkman; E Yu Bazhenova; N A Sinyakova; V S Naumenko
Journal:  Mol Neurobiol       Date:  2014-08-02       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.